Rallybio Corp. (RLYB)
16.73
-0.14
(-0.86%)
USD |
NASDAQ |
Sep 14, 10:53
Rallybio Price to Book Value : 0.9396 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.9477 |
| September 10, 2026 | 0.9407 |
| September 09, 2026 | 0.953 |
| September 08, 2026 | 0.9328 |
| September 04, 2026 | 0.9505 |
| September 03, 2026 | 0.9477 |
| September 02, 2026 | 0.9514 |
| September 01, 2026 | 0.9373 |
| August 31, 2026 | 0.9429 |
| August 28, 2026 | 0.9441 |
| August 27, 2026 | 0.9412 |
| August 26, 2026 | 0.948 |
| August 25, 2026 | 0.9483 |
| August 24, 2026 | 0.9435 |
| August 21, 2026 | 0.9452 |
| August 20, 2026 | 0.9323 |
| August 19, 2026 | 0.9547 |
| August 18, 2026 | 0.9418 |
| August 17, 2026 | 0.9547 |
| August 14, 2026 | 0.9542 |
| August 13, 2026 | 0.9525 |
| August 12, 2026 | 0.9317 |
| August 11, 2026 | 0.9199 |
| August 10, 2026 | 0.9328 |
| August 07, 2026 | 0.9075 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.9092 |
| August 05, 2026 | 0.9064 |
| August 04, 2026 | 0.8963 |
| August 03, 2026 | 0.8958 |
| July 31, 2026 | 0.8946 |
| July 30, 2026 | 0.9025 |
| July 29, 2026 | 0.8963 |
| July 28, 2026 | 0.9073 |
| July 27, 2026 | 0.916 |
| July 24, 2026 | 0.916 |
| July 23, 2026 | 0.9205 |
| July 22, 2026 | 0.9334 |
| July 21, 2026 | 0.9497 |
| July 20, 2026 | 0.9384 |
| July 17, 2026 | 0.9221 |
| July 16, 2026 | 0.8963 |
| July 15, 2026 | 0.9059 |
| July 14, 2026 | 0.8991 |
| July 13, 2026 | 0.8924 |
| July 10, 2026 | 0.8834 |
| July 09, 2026 | 0.889 |
| July 08, 2026 | 0.8806 |
| July 07, 2026 | 0.88 |
| July 06, 2026 | 0.8828 |
| July 02, 2026 | 0.8882 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.355 |
| C4 Therapeutics, Inc. | 1.735 |
| Cullinan Therapeutics, Inc. | 4.004 |
| Q32 Bio, Inc. | 2.450 |
| Arrowhead Pharmaceuticals, Inc. | 24.68 |
Price to Book Value Related Metrics
| PE Ratio | 2.142 |
| PS Ratio | 145.04 |
| Price to Free Cash Flow | 3.508 |
| Price | 16.73 |
| Earnings Yield | 46.69% |
| Market Cap | 88.78M |
| Normalized PE Ratio | 6.749 |